RENAL OUTCOMES IN DIABETIC KIDNEY PATIENTS TREATED WITH GLP1 AGONIST RECEPTORS VS SGLT2 INHIBITORS

被引：0
|
作者：
Maroto, Alba [1 ]
Vidas, Maria Marques [1 ]
Sanz, Ignacio [1 ]
Lopez, Paula [1 ]
Portoles, Jose' M. [1 ]
机构：
[1] Hosp Univ Puerta Hierro Majadahonda Madrid, Nephrol, Majadahonda, Spain
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P1009
引用
下载
收藏
页码：1331 / 1331
页数：1
相关论文
共 50 条
  • [41] Effects of SGLT2 Inhibitors on Renal Outcomes in Patients With Chronic Kidney Disease: A Meta-Analysis
    Li, Ning
    Lv, Dan
    Zhu, Xiangjun
    Wei, Ping
    Gui, Yuan
    Liu, Shijia
    Zhou, Enchao
    Zheng, Min
    Zhou, Dong
    Zhang, Lu
    FRONTIERS IN MEDICINE, 2021, 8
  • [42] The Enhanced Cardiac Outcome of Conjugated SGLT2 Inhibitors and GLP-1RA Therapy in Diabetic Patients
    Fadah, Kahtan
    Alashi, Alaa
    Deoker, Abhizith
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (01) : 17 - 22
  • [43] Diabetic ketoacidosis in patients treated with SGLT2 inhibitors: experience at a tertiary hospital
    Papanastasiou, Labrini
    Glycofridi, Spyridoula
    Gravvanis, Christos
    Skarakis, Nikitas
    Papadimitriou, Irene
    Kanti, Georgia
    Kapsali, Chara
    Kounadi, Theodora
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2021, 20 (02): : 369 - 376
  • [44] The Enhanced Cardiac Outcome of Conjugated SGLT2 Inhibitors and GLP-1RA Therapy in Diabetic Patients
    Kahtan Fadah
    Alaa Alashi
    Abhizith Deoker
    Current Cardiology Reports, 2022, 24 : 17 - 22
  • [45] Are SGLT2 inhibitors a targeted treatment for diabetic kidney disease?
    Kanda, Eiichiro
    Nangaku, Masaomi
    KIDNEY INTERNATIONAL, 2019, 96 (01) : 8 - 10
  • [46] Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
    Ralph A. DeFronzo
    W. Brian Reeves
    Alaa S. Awad
    Nature Reviews Nephrology, 2021, 17 : 319 - 334
  • [47] Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
    DeFronzo, Ralph A.
    Reeves, W. Brian
    Awad, Alaa S.
    NATURE REVIEWS NEPHROLOGY, 2021, 17 (05) : 319 - 334
  • [48] SGLT2 inhibitors in non-diabetic kidney disease
    Tesar, Vladimir
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 31 (02): : 105 - 107
  • [49] Combination therapy with SGLT2 inhibitors for diabetic kidney disease
    Cai, Yuwen
    Liu, Xin
    Xu, Gaosi
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 127
  • [50] Cardiovascular outcomes and safety of SGLT2 inhibitors in chronic kidney disease patients
    Chen, Xiutian
    Wang, Jiali
    Lin, Yongda
    Yao, Kaijin
    Xie, Yina
    Zhou, Tianbiao
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
12345